Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-02

Clinical Trial Update: Incretin Based Therapy for Poorly Controlled Type 2 Diabetic Patients

View source ↗

Summary

A completed clinical trial evaluating incretin-based therapy in patients with poorly controlled Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Incretin-based therapy

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED